HYRDOGLAD-25 Tablet | For Allergy and Anxiety Relief

Price:

1,400.00

Hydroxyzine Hydrochloride IP 25 mg Tablets

Packaging – 10 × 10 Tablets (ALU ALU)

Category:

Description

Product Description

HYRDOGLAD-25 Tablet contains Hydroxyzine Hydrochloride 25 mg, an antihistamine used to relieve allergic reactions, itching, and anxiety-related symptoms. It works by blocking histamine and producing a calming effect on the central nervous system.

This medicine helps manage allergic conditions, hives, skin rashes, and mild anxiety, providing faster relief and overall comfort.

Uses

  • Allergic reactions
  • Itching and hives
  • Skin rashes
  • Anxiety and tension
  • Sedative for sleep disturbances

Benefits

  • Helps relieve allergy symptoms
  • Reduces itching and skin irritation
  • Provides calming and anti-anxiety effects
  • Supports better sleep and daily comfort

Composition

  • Hydroxyzine Hydrochloride IP 25 mg
    Hydroxyzine is an antihistamine that blocks histamine and provides sedative effects, helping relieve allergies, itching, and mild anxiety.

Dosage

  • Take the tablet as directed by a healthcare professional.
  • Swallow with water, preferably after meals.

Side Effects

Some people may experience mild side effects such as:

  • Drowsiness
  • Dry mouth
  • Dizziness
  • Nausea

If any side effects persist or worsen, consult a healthcare professional.

Storage

  • Store in a cool and dry place
  • Protect from direct sunlight
  • Keep out of reach of children

Safety Information

  • Use under medical supervision
  • Do not exceed the recommended dosage
  • Avoid alcohol while taking this medication
  • Inform your doctor about existing medical conditions or medications

Uses

  1. Musculoskeletal Disorders
  2. Arthritis
  3. Low Back Pain
  4. Ankylosing Spondylitis

Customer reviews

0
0 ratings
1 Star
0%
2 Star
0%
3 Star
0%
4 Star
0%
5 Star
0%

Reviews

There are no reviews yet.

Be the first to review “HYRDOGLAD-25 Tablet | For Allergy and Anxiety Relief”

Your email address will not be published. Required fields are marked *